GSK today announced that it has submitted a regulatory application to the European Medicines Agency (EMA) for its antiseptic chlorhexidine gel (7.1% chlorhexidine digluconate gel, equivalent to 4% chlorhexidine) for the prevention of umbilical cord infections (omphalitis) in newborn babies. GSK’s work to develop the gel began in response to a call from the United Nations (UN) in 2012 for manufacturers to make a high quality chlorhexidine product suitable for newborn infants in low resources settings.

Tue, 10/13/2015 - 14:10

What does biomimicry have to do with Green Money? Well, everything. Biomimicry is the conscious emulation of nature’s wisdom, a methodology that is based not on harvesting nature but on learning from nature. This approach is beginning to shape our cities, our companies, and our social sphere, and has profound implications for investing and for life.

Wed, 10/14/2015 - 10:10

Mon, 10/12/2015 - 17:45

Mon, 10/12/2015 - 17:40

Thu, 10/15/2015 - 09:35

Preschoolers at Zion Elementary School in Anaheim, CA, had an up-close and personal experience with one of Republic Services’ collections trucks earlier this week.

Tue, 10/20/2015 - 13:45

Tue, 10/13/2015 - 08:05

Mon, 10/12/2015 - 12:05

Mon, 10/12/2015 - 15:25

Mon, 10/12/2015 - 17:00